Mechanisms by which a phytotherapeutic drug influences bladder activity in rats

Journal of Urology

Volumn 179, Issue 2, 2008, Pages 770-774

  Sugaya, Kimio ^a   Nishijima, Saori ^a   Tasaki, Shinsuke ^a   Kadekawa, Katsumi ^a   Miyazato, Minoru ^a   Ogawa, Yoshihide ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Adenosine triphosphate; Bladder; Catecholamines; Eviprostat; Urination disorders

Indexed keywords

ACETIC ACID; ADENOSINE TRIPHOSPHATE; ADRENALIN; CATECHOLAMINE; DOPAMINE; EVIPROSTAT; MONOAMINE; NORADRENALIN; SEROTONIN; SODIUM CHLORIDE; ETAMSYLATE; PLANT EXTRACT;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLADDER CONTRACTION; BLADDER FUNCTION; BLADDER PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CYSTOMETRY; DIASTOLIC BLOOD PRESSURE; DOPAMINE BLOOD LEVEL; DRUG MECHANISM; FEMALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; URINALYSIS; ANIMAL; BLADDER; BLOOD PRESSURE; DRUG COMBINATION; DRUG EFFECT; METABOLISM; ORGAN SIZE; PATHOPHYSIOLOGY; PHYTOTHERAPY; SPRAGUE DAWLEY RAT; URINE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD PRESSURE; DRUG COMBINATIONS; ETHAMSYLATE; FEMALE; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER;

EID: 38849140489     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.09.023     Document Type: Article

References (20)

1. Garraway WM, Collins GN and Lee RJ: High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469.
2. McVary KT, Rademaker A, Lloyd GL and Gann P: Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2005;174:1327.
3. Sugaya K, Kadekawa K, Ikehara A, Nakayama T, Gakiya M, Nashiro F et al: Influence of hypertension on lower urinary tract symptoms in benign prostatic hyperplasia. Int J Urol 2003;10:569.
4. Chapple CR: Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. BJU Int 2004;94:738.
5. Ishihama H, Momota Y, Yanase H, Wang X, de Groat WC and Kawatani M: Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 2006;175:358.
6. Bales GT, Christiano AP, Kirsh EJ and Gerber GS: Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology 1999;54:86.
7. Song Y, Li NC, Wang XF, Ma LL, Wan B, Hong BF et al: Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia. Zhonghua Nan Ke Xue 2005;11:674.
8. Nishijima S, Sugaya K, Miyazato M and Ogawa Y: Effect of Gosha-jinki-gan, a blended herbal medicine, on bladder activity in rats. J Urol 2007;177:762.
9. Kinoshita H, Kawamura N, Miyakita H, Tanaka M, Watanabe S, Onda H et al: The effects of combination therapy using Eviprostat® and tamsulosin hydrochloride (Harnal®) for benign prostatic hyperplasia. Hinyouki Geka 1998;11:1297.
10. Ishigooka M, Hashimoto T, Hayami S, Tomaru M, Nakada T and Mitobe K: Clinical and retrospective evaluation of Eviprostat: a non-hormonal and non-neuropharmacological agent for benign prostatic hyperplasia. Int Urol Nephrol 1995;27:61.
11. Ishigami J, Kodama H and Sato K: Clinical use of eviprostat for prostatic hypertrophy. Dermatol Urol 1966;28:474.
12. Boyle P, Robertson C, Lowe F and Roehrborn C: Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int 2004;93:751.
13. Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC et al: Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Eur Urol 2002;41:497.
14. Sugaya K, Nishijima S, Miyazato M, Chinen Y, Morozumi M and Ogawa Y: Intravenous noradrenalin facilitates afferent activity of the micturition reflex at the lumbosacral cord in rats. Presented at annual meeting of the International Continence Society, Paris, France, August 25-27, 2004.
15. Gillespie JI: Noradrenaline inhibited autonomous activity in the isolated guinea pig bladder. BJU Int 2004;93:401.
16. Andersson KE and Yoshida M: Antimuscarinics and the overactive detrusor: which is the main mechanism of action? Eur Urol 2006;43:1.
17. Yoshida M, Inadome A, Murakami S, Miyamae K, Iwashita H, Otani M et al: Effects of age and muscle stretching on acetylcholine release in isolated human bladder smooth muscles. J Urol, suppl., 2002;167:40
18. Sun Y, Keay S, De Deyne PG and Chai TC: Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 2001;166:1951.
19. Sherer TB, Spitsbergen JM, Steers WD and Tuttle JB: Thrombin regulates nerve growth factor secretion from vascular, but not bladder smooth muscle cells. Cell Tissue Res 1997;289:155.
20. Oka M, Tachibana M, Noda K, Inoue N, Tanaka M and Kuwabara K: Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of Eviprostat ®, a phytotherapeutic agent for benign prostatic hyperplasia. Phytomedicine 2007;14:465.